35.17
+1.245(+3.67%)
Currency In USD
| Previous Close | 33.92 |
| Open | 33.73 |
| Day High | 35.23 |
| Day Low | 33.44 |
| 52-Week High | 87.45 |
| 52-Week Low | 27.8 |
| Volume | 483,370 |
| Average Volume | 1.44M |
| Market Cap | 1.96B |
| PE | -22.98 |
| EPS | -1.53 |
| Moving Average 50 Days | 32.71 |
| Moving Average 200 Days | 45.24 |
| Change | 1.25 |
If you invested $1000 in PROCEPT BioRobotics Corporation (PRCT) since IPO date, it would be worth $838.46 as of January 08, 2026 at a share price of $35.165. Whereas If you bought $1000 worth of PROCEPT BioRobotics Corporation (PRCT) shares 3 years ago, it would be worth $952.98 as of January 08, 2026 at a share price of $35.165.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025
GlobeNewswire Inc.
Nov 20, 2025 9:03 PM GMT
SAN JOSE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of
PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025
GlobeNewswire Inc.
Oct 15, 2025 8:03 PM GMT
SAN JOSE, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
GlobeNewswire Inc.
Jul 24, 2025 10:00 PM GMT
Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing annual growth of 48% SAN JOSE, Calif., July 24, 2025